CARENET

A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent: The CGuard™ CARENET Trial (Carotid Embolic Protection Using MicroNet^TM)

Objective: Evaluate the feasibility of the CGuard™ Carotid Embolic Protective Stent system in treating carotid artery lesions in consecutive patients (N=30) suitable for carotid artery stenting.

Conclusion: The CGuard™ system is feasible for patients undergoing carotid artery stenting. In addition, the benefit of using CGuard™ may extend throughout the stent healing period.